DrugPatentWatch Database Preview
Ge Healthcare Company Profile
What is the competitive landscape for GE HEALTHCARE, and when can generic versions of GE HEALTHCARE drugs launch?
GE HEALTHCARE has fifty-four approved drugs.
There are seven US patents protecting GE HEALTHCARE drugs.
There are one hundred and fifteen patent family members on GE HEALTHCARE drugs in thirty-two countries and eighty-three supplementary protection certificates in fifteen countries.
Summary for Ge Healthcare
| International Patents: | 115 |
| US Patents: | 7 |
| Tradenames: | 62 |
| Ingredients: | 42 |
| NDAs: | 54 |
| Drug Master File Entries: | 5 |
| Patent Litigation for Ge Healthcare: | See patent lawsuits for Ge Healthcare |
Drugs and US Patents for Ge Healthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | HYPAQUE | diatrizoate sodium | INJECTABLE;INJECTION | 009561-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Ge Healthcare | NEPHROFLOW | iodohippurate sodium i-123 | INJECTABLE;INJECTION | 018289-001 | Dec 28, 1984 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Ge Healthcare | VIZAMYL | flutemetamol f-18 | INJECTABLE;INTRAVENOUS | 203137-001 | Oct 25, 2013 | DISCN | Yes | No | 8,916,131 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Ge Healthcare | OMNIPAQUE 180 | iohexol | SOLUTION;INJECTION, ORAL, RECTAL | 018956-001 | Dec 26, 1985 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Ge Healthcare | OMNIPAQUE 70 | iohexol | SOLUTION;URETHRAL | 018956-007 | Jun 1, 1994 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Ge Healthcare | ADREVIEW | iobenguane sulfate i-123 | SOLUTION;INTRAVENOUS | 022290-001 | Sep 19, 2008 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Ge Healthcare | HYPAQUE SODIUM 20% | diatrizoate sodium | SOLUTION;URETERAL | 009561-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Ge Healthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020351-002 | Mar 22, 1996 | 4,396,597 | ➤ Sign Up |
| Ge Healthcare | OMNIPAQUE 350 | iohexol | SOLUTION;INJECTION, ORAL | 018956-004 | Dec 26, 1985 | 4,250,113 | ➤ Sign Up |
| Ge Healthcare | MPI DMSA KIDNEY REAGENT | technetium tc-99m succimer kit | INJECTABLE;INJECTION | 017944-001 | May 18, 1982 | 4,208,398 | ➤ Sign Up |
| Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020351-001 | Mar 22, 1996 | 4,396,597 | ➤ Sign Up |
| Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020351-002 | Mar 22, 1996 | RE36418 | ➤ Sign Up |
| Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020808-001 | Aug 29, 1997 | 4,278,654 | ➤ Sign Up |
| Ge Healthcare | AMIPAQUE | metrizamide | INJECTABLE;INJECTION | 017982-001 | Approved Prior to Jan 1, 1982 | 3,701,771 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for Ge Healthcare Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hungary | 1500560 | ➤ Sign Up |
| Japan | 3231768 | ➤ Sign Up |
| Australia | 2011200667 | ➤ Sign Up |
| Luxembourg | 92634 | ➤ Sign Up |
| Russian Federation | 2475267 | ➤ Sign Up |
| Denmark | 2264018 | ➤ Sign Up |
| Hungary | 0302956 | ➤ Sign Up |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for Ge Healthcare Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2203431 | 15C0013 | France | ➤ Sign Up | PRODUCT NAME: DASABUVIR OU UN SEL DE CELUI-CI, NOTAMMENT LE SEL DE SODIUM; REGISTRATION NO/DATE: EU/1/14/983 20150119 |
| 0480717 | SPC/GB98/025 | United Kingdom | ➤ Sign Up | PRODUCT NAME: MONTELUKAST, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREFERABLY MONTELUKAST SODIUM; REGISTERED: FI 12766 19970825; FI 12767 19970825; UK 00025/0357 19980115; UK 00025/0358 19980115 |
| 1611115 | 2015/004 | Ireland | ➤ Sign Up | PRODUCT NAME: VIZAMYL-FLUTEMETAMOL (18F); REGISTRATION NO/DATE: EU/1/14/941 20140822 |
| 1666481 | 17C1031 | France | ➤ Sign Up | PRODUCT NAME: TOFACITINIB,EVENTUELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,DONT LE CITRATE DE SODIUM; REGISTRATION NO/DATE: EU/1/17/1178 20170324 |
| 1853250 | 37/2014 | Austria | ➤ Sign Up | PRODUCT NAME: PACLITAXEL, DAS ALS ALBUMIN GEBUNDENE NANOPARTIKEL FORMUIERT IST.; REGISTRATION NO/DATE: EU/1/07/428 (MITTEILUNG) (GEAENDERT DURCH C(2013) 9835) 20131230 |
| 0806968 | SPC/GB07/011 | United Kingdom | ➤ Sign Up | PRODUCT NAME: GADOFOSVESET TRISODIUM; REGISTERED: UK EU/1/05/313/001 20051003; UK EU/1/05/313/002 20051003; UK EU/1/05/313/003 20051003; UK EU/1/05/313/004 20051003; UK EU/1/05/313/005 20051003; UK EU/1/05/313/006 20051003; UK EU/1/05/313/007 20051003; UK EU/1/05/313/008 20051003; UK EU/1/05/313/009 20051003 |
| 0579826 | 02C0041 | France | ➤ Sign Up | PRODUCT NAME: ERTAPENEM SODIUM; REGISTRATION NO/DATE: EU/1/02/216/001 20020418 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
